Clinical trial

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

Johns Hopkins UniversityRecruitingPhase 1Started Feb 9, 202620 enrolledUnited StatesNCT07053917

Abstract

The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

psychedelicstrokechronic strokeintracerebral hemorrhagestroke recoverymotor recoverypoststroke recoverypoststroke motor recoveryhemiparesis recoverypsychedelic safetyStrokeChronic StrokeIntracerebral HaemorrhageIntracerebral Haemorrhage (ICH)Intracerebral Hemorrhage Basal Ganglia

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Association of Psilocybin Use in Adolescents with Major Depressive Episode

Shah K, Trivedi C, Kamrai D +2

Europe PMC2022

ArticlePsilocybin

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.

Spain A, Howarth C, Khrapitchev AA +3

Europe PMC2015

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023